Try our Advanced Search for more refined results
September 28, 2018
Securities and Exchange Commission v. Salix Pharmaceuticals, Ltd.
Case Number:
1:18-cv-08886
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 28, 2018
Ex-Salix CFO Pays $1M To End Claims He Misled Investors
The U.S. Securities and Exchange Commission on Friday charged Salix Pharmaceuticals Ltd. and its former chief financial officer with repeatedly misleading investors about the amount of Salix drugs that wholesale customers were holding in inventory, with the executive agreeing to pay $1 million to settle the charges.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login